Recent advances in epidermal growth factor receptor inhibitors (EGFRIs) and their role in the treatment of cancer: a review

A Unnisa, AK Chettupalli, T Hussain… - Anti-Cancer Agents in …, 2022 - ingentaconnect.com
Tyrosine kinases are known to play a role in tumour growth and proliferation, and they have
become common drug targets. Tyrosine kinase inhibitors (TKIs) prohibit associated kinases …

[HTML][HTML] Upfront cranial radiotherapy vs. EGFR tyrosine kinase inhibitors alone for the treatment of brain metastases from non-small-cell lung cancer: a meta-analysis …

XJ Du, SM Pan, SZ Lai, XN Xu, ML Deng… - Frontiers in …, 2018 - frontiersin.org
Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is
revolutionizing the management of brain metastases (BMs). This study was to explore the …

[HTML][HTML] Efficacy of alectinib in patients with ALK-positive NSCLC and symptomatic or large CNS metastases

JJ Lin, GY Jiang, N Joshipura, J Ackil… - Journal of Thoracic …, 2019 - Elsevier
Background Central nervous system (CNS) metastases represent a significant source of
morbidity and mortality for patients with ALK tyrosine kinase gene (ALK)-positive NSCLC …

Combined stereotactic radiosurgery and tyrosine kinase inhibitor therapy versus tyrosine kinase inhibitor therapy alone for the treatment of non–small cell lung cancer …

GY Chiou, CL Chiang, HC Yang, CI Shen… - Journal of …, 2021 - thejns.org
OBJECTIVE Whether combined radiation and tyrosine kinase inhibitor (TKI) therapy in non–
small cell lung cancer (NSCLC) patients with brain metastases (BMs) and epidermal growth …

[HTML][HTML] Identification of two subtypes and prognostic characteristics of lung adenocarcinoma based on pentose phosphate metabolic pathway-related long non …

C Liu, Y Wang - Frontiers in public health, 2022 - frontiersin.org
This study analyzed the differences in subtypes and characteristics of advanced lung
adenocarcinoma (LUAD) patients based on the pentose phosphate metabolic pathway …

Novel 4-arylaminoquinazolines bearing N,N-diethyl(aminoethyl)amino moiety with antitumour activity as EGFRwt-TK inhibitor

Y Zhang, L Chen, X Li, L Gao, Y Hao… - Journal of Enzyme …, 2019 - Taylor & Francis
Herein, four novel 4-arylaminoquinazoline derivatives with N, N-diethyl (aminoethyl) amino
moiety were designed, synthesised and evaluated on biological activities in vitro. All …

Современные представления о молекулярных мишенях в опухолях лёгкого

ЕН Имянитов - Практическая онкология, 2018 - elibrary.ru
Рак лёгкого (РЛ) является самым частым онкологическим заболеванием. Возможности
лечения РЛ в значительной мере зависят от того, вызв н ли опухоль курением или её …

Breast cancer mutation in GATA3 zinc finger 1 induces conformational changes leading to the closer binding of ZnFn2 with a wrapping architecture

R Karn, IA Emerson - Journal of Biomolecular Structure and …, 2019 - Taylor & Francis
GATA3 is a transcription factor, known to regulate the transcriptional network and several
pathways using two zinc fingers. Its mutation is associated with a higher risk of breast …

Epigenetic modifications and potential treatment approaches in lung cancers

M Budak, M Yildiz - Lung Cancer-Strategies for Diagnosis and …, 2018 - books.google.com
Alteration of methylation is a process seen across a wide variety of species ranging from
bacterial microorganisms to mammals, defined as the adaptation method the organism …

[HTML][HTML] Identifying Topics and Evolutionary Trends of Literature on Brain Metastases Using Latent Dirichlet Allocation

J Chen, M Williams, Y Huang, S Si - Frontiers in Molecular …, 2022 - frontiersin.org
Research on brain metastases kept innovating. We aimed to illustrate what topics the
research focused on and how it varied in different periods of all the studies on brain …